— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...

Please provide your email address to receive an email when new articles are posted on . The expanded label includes administration as adductor canal block and sciatic nerve block in the popliteal ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for Exparel (bupivacaine liposome injectable suspension) to include both single-dose sciatic nerve ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Pacira Biosciences PCRX announced that the FDA has accepted for review its supplemental new drug application (sNDA) for Exparel. The sNDA seeks to expand Exparel’s label to include a single-dose ...

Please provide your email address to receive an email when new articles are posted on . A mid-calf nerve block may lead to early rehabilitation after total ankle replacement. The mid-calf nerve block ...

Ultrasound-guided peripheral nerve blocks have a higher success rate compared to nerve stimulation or other methods, according to a study conducted by the Department of Anesthesiology at Johns Hopkins ...

A nerve block works by preventing pain signals from reaching the brain. There are permanent and temporary options. Both are generally safe procedures. Nerve blocks are an effective way to prevent, ...